A Health and Human Services Department watchdog will review FDA’s actions leading up to the infant formula recall at the Abbott facility in February 2022, the department says on website.
- Move seeks to determine whether FDA followed procedures for conducting inspections of the manufacturing facility and for overseeing Abbott’s infant formula recall
- NOTE:
Baby-Formula Makers Tell Biden They Knew Shortages Would Be Dire
To contact the reporter on this story:
To contact the editors responsible for this story:
Megan Howard, Maria Luiza Rabello
© 2022 Bloomberg ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.